Evolent Stock Based Compensation from 2010 to 2025

EVH Stock

USD 9.79 0.58 5.59%

Evolent Health's Stock Based Compensation is increasing with slightly volatile movements from year to year. Stock Based Compensation is estimated to finish at about 48.9 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2014-03-31

Previous Quarter

12.7 M

Current Value

14.4 M

Quarterly Volatility

3.9 M

Yuan Drop

Covid

Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 149 M, Total Revenue of 2.4 B or Gross Profit of 556 M, as well as many indicators such as Price To Sales Ratio of 2.04, Dividend Yield of 0.0072 or PTB Ratio of 3.25. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.

Check out the analysis of Evolent Health Correlation against competitors.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Latest Evolent Health's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Evolent Health over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Evolent Health's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Evolent Stock Based Compensation Regression Statistics

	Arithmetic Mean	19,203,569
	Geometric Mean	5,704,709
	Coefficient Of Variation	83.54
	Mean Deviation	12,209,962
	Median	16,711,000
	Standard Deviation	16,041,972
	Sample Variance	257.3T
	Range	48.8M
	R-Value	0.91
	Mean Square Error	49.4T
	R-Squared	0.82
	Slope	3,052,886
	Total Sum of Squares	3860.2T

Evolent Stock Based Compensation History

	2025	48.9 M
	2024	46.6 M
	2023	40.5 M
	2022	34 M
	2021	16.7 M
	2020	14.6 M
	2019	15.6 M

Other Fundumenentals of Evolent Health

Stock Based Compensation To Revenue

Evolent Health Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Current Deferred Revenue	Short Term Investments	Short Term Debt	Property Plant Equipment	Net Tangible Assets	Long Term Debt	Good Will	Deferred Long Term Liab	Long Term Investments	Common Stock	Capital Surpluse	Long Term Debt Total	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.84	0.83	-0.68	0.56	0.91	0.95	0.96	0.98	-0.59	0.19	-0.15	0.79	-0.65	0.88	0.59	-0.66	-0.33	0.91	0.85	0.79	-0.79	0.51	0.65	-0.83	0.79
Total Stockholder Equity	0.84		0.52	-0.4	0.73	0.59	0.66	0.8	0.75	-0.19	0.26	0.16	0.81	-0.36	0.55	0.49	-0.58	-0.2	0.95	0.82	0.68	-0.69	0.47	0.54	-0.61	0.55
Net Debt	0.83	0.52		-0.78	0.23	0.92	0.92	0.75	0.9	-0.76	-0.11	-0.58	0.66	-0.74	0.97	0.66	-0.58	-0.1	0.65	0.73	0.85	-0.73	0.2	0.73	-0.91	0.86
Retained Earnings	-0.68	-0.4	-0.78		-0.29	-0.79	-0.83	-0.76	-0.71	0.79	-0.11	0.64	-0.79	0.56	-0.82	-0.33	0.78	0.26	-0.64	-0.83	-0.82	0.83	-0.56	-0.37	0.89	-0.75
Accounts Payable	0.56	0.73	0.23	-0.29		0.31	0.41	0.62	0.46	-0.06	0.31	0.22	0.65	-0.09	0.31	0.2	-0.24	-0.31	0.65	0.63	0.4	-0.66	0.55	0.23	-0.36	0.23
Net Receivables	0.91	0.59	0.92	-0.79	0.31		0.98	0.88	0.97	-0.81	0.08	-0.38	0.66	-0.77	0.98	0.7	-0.6	-0.39	0.72	0.75	0.81	-0.7	0.42	0.74	-0.85	0.91
Total Liab	0.95	0.66	0.92	-0.83	0.41	0.98		0.93	0.98	-0.77	0.1	-0.38	0.76	-0.72	0.98	0.63	-0.66	-0.35	0.79	0.83	0.84	-0.8	0.49	0.69	-0.9	0.88
Total Current Assets	0.96	0.8	0.75	-0.76	0.62	0.88	0.93		0.93	-0.6	0.27	-0.17	0.83	-0.58	0.84	0.49	-0.7	-0.48	0.89	0.88	0.76	-0.82	0.72	0.53	-0.79	0.75
Intangible Assets	0.98	0.75	0.9	-0.71	0.46	0.97	0.98	0.93		-0.68	0.13	-0.25	0.73	-0.73	0.94	0.67	-0.62	-0.35	0.83	0.81	0.81	-0.75	0.44	0.73	-0.85	0.86
Current Deferred Revenue	-0.59	-0.19	-0.76	0.79	-0.06	-0.81	-0.77	-0.6	-0.68		0.08	0.55	-0.44	0.84	-0.78	-0.51	0.4	0.35	-0.43	-0.54	-0.72	0.56	-0.24	-0.52	0.74	-0.81
Short Term Investments	0.19	0.26	-0.11	-0.11	0.31	0.08	0.1	0.27	0.13	0.08		0.31	0.17	0.05	-0.02	-0.15	-0.38	-0.44	0.29	0.21	-0.1	-0.01	0.37	-0.21	-0.08	0.03
Short Term Debt	-0.15	0.16	-0.58	0.64	0.22	-0.38	-0.38	-0.17	-0.25	0.55	0.31		-0.25	0.29	-0.48	-0.16	0.38	-0.17	-0.04	-0.3	-0.44	0.37	0.01	-0.2	0.56	-0.42
Property Plant Equipment	0.79	0.81	0.66	-0.79	0.65	0.66	0.76	0.83	0.73	-0.44	0.17	-0.25		-0.37	0.71	0.38	-0.79	-0.14	0.9	0.98	0.87	-0.93	0.62	0.44	-0.84	0.65
Net Tangible Assets	-0.65	-0.36	-0.74	0.56	-0.09	-0.77	-0.72	-0.58	-0.73	0.84	0.05	0.29	-0.37		-0.72	-0.63	0.25	0.4	-0.52	-0.47	-0.68	0.42	-0.04	-0.62	0.63	-0.77
Long Term Debt	0.88	0.55	0.97	-0.82	0.31	0.98	0.98	0.84	0.94	-0.78	-0.02	-0.48	0.71	-0.72		0.67	-0.61	-0.27	0.68	0.78	0.85	-0.76	0.37	0.73	-0.89	0.89
Good Will	0.59	0.49	0.66	-0.33	0.2	0.7	0.63	0.49	0.67	-0.51	-0.15	-0.16	0.38	-0.63	0.67		-0.11	-0.27	0.47	0.46	0.66	-0.3	-0.04	0.99	-0.46	0.84
Deferred Long Term Liab	-0.66	-0.58	-0.58	0.78	-0.24	-0.6	-0.66	-0.7	-0.62	0.4	-0.38	0.38	-0.79	0.25	-0.61	-0.11		0.08	-0.73	-0.81	-0.65	0.68	-0.59	-0.16	0.78	-0.52
Long Term Investments	-0.33	-0.2	-0.1	0.26	-0.31	-0.39	-0.35	-0.48	-0.35	0.35	-0.44	-0.17	-0.14	0.4	-0.27	-0.27	0.08		-0.27	-0.25	-0.15	0.08	-0.58	-0.18	0.03	-0.36
Common Stock	0.91	0.95	0.65	-0.64	0.65	0.72	0.79	0.89	0.83	-0.43	0.29	-0.04	0.9	-0.52	0.68	0.47	-0.73	-0.27		0.93	0.81	-0.81	0.57	0.51	-0.77	0.68
Capital Surpluse	0.85	0.82	0.73	-0.83	0.63	0.75	0.83	0.88	0.81	-0.54	0.21	-0.3	0.98	-0.47	0.78	0.46	-0.81	-0.25	0.93		0.9	-0.91	0.63	0.52	-0.87	0.74
Long Term Debt Total	0.79	0.68	0.85	-0.82	0.4	0.81	0.84	0.76	0.81	-0.72	-0.1	-0.44	0.87	-0.68	0.85	0.66	-0.65	-0.15	0.81	0.9		-0.84	0.35	0.71	-0.89	0.87
Short Long Term Debt	-0.79	-0.69	-0.73	0.83	-0.66	-0.7	-0.8	-0.82	-0.75	0.56	-0.01	0.37	-0.93	0.42	-0.76	-0.3	0.68	0.08	-0.81	-0.91	-0.84		-0.58	-0.4	0.87	-0.6
Cash And Equivalents	0.51	0.47	0.2	-0.56	0.55	0.42	0.49	0.72	0.44	-0.24	0.37	0.01	0.62	-0.04	0.37	-0.04	-0.59	-0.58	0.57	0.63	0.35	-0.58		-0.02	-0.35	0.29
Net Invested Capital	0.65	0.54	0.73	-0.37	0.23	0.74	0.69	0.53	0.73	-0.52	-0.21	-0.2	0.44	-0.62	0.73	0.99	-0.16	-0.18	0.51	0.52	0.71	-0.4	-0.02		-0.54	0.85
Net Working Capital	-0.83	-0.61	-0.91	0.89	-0.36	-0.85	-0.9	-0.79	-0.85	0.74	-0.08	0.56	-0.84	0.63	-0.89	-0.46	0.78	0.03	-0.77	-0.87	-0.89	0.87	-0.35	-0.54		-0.79
Capital Stock	0.79	0.55	0.86	-0.75	0.23	0.91	0.88	0.75	0.86	-0.81	0.03	-0.42	0.65	-0.77	0.89	0.84	-0.52	-0.36	0.68	0.74	0.87	-0.6	0.29	0.85	-0.79

Click cells to compare fundamentals

About Evolent Health Financial Statements

Investors use fundamental indicators, such as Evolent Health's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Stock Based Compensation	46.6 M	48.9 M
Stock Based Compensation To Revenue	0.02	0.04

Currently Active Assets on Macroaxis

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation
BVHMF	Vistry Group PLC
S	SentinelOne

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:

How To Invest In Evolent

Details

Is Evolent Stock a good investment?

Details

What is Evolent Health's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Evolent Health Correlation against competitors.

For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

21.554

Quarterly Revenue Growth

0.216

Return On Assets

0.0073

Return On Equity

(0.06)

The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Evolent Stock Based Compensation from 2010 to 2025

Latest Evolent Health's Stock Based Compensation Growth Pattern

Evolent Stock Based Compensation Regression Statistics

Evolent Stock Based Compensation History

Other Fundumenentals of Evolent Health

Evolent Health Stock Based Compensation component correlations

About Evolent Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY